Publications in collaboration with researchers from Hospital Universitario de Salamanca (114)


  1. Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1


  1. Clinical Efficacy and Safety of Fanhdi®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, Vol. 28

  2. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

    Medicina Clinica, Vol. 158, Núm. 2, pp. 82-89

  3. Novel Therapies to Address Unmet Needs in ITP

    Pharmaceuticals, Vol. 15, Núm. 7

  4. Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 770-783

  5. Vascular target organ damage in patients with Philadelphia negative myeloproliferative syndrome: A propensity score analysis

    Medicina Clinica, Vol. 158, Núm. 11, pp. 503-508


  1. ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction

    Platelets, Vol. 32, Núm. 4, pp. 573-577

  2. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

    Blood Cells, Molecules, and Diseases, Vol. 86

  3. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis

    American Journal of Hematology

  4. Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)

    Scientific Reports

  5. C-Reactive protein and SOFA scale: A simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 68, Núm. 9, pp. 513-522

  6. Characterization of the platelet phenotype caused by a germline RUNX1 Variant in a CRISPR/Cas9-generated murine model

    Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1193-1205

  7. Elucidating the mechanism of action of the attributed immunomodulatory role of eltrombopag in primary immune thrombocytopenia: An in silico approach

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

  8. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain

    British Journal of Haematology, Vol. 194, Núm. 3, pp. 537-541


  1. Acquired haemophilia a in association with influenza a and urinary tract infection

    European Journal of Case Reports in Internal Medicine, Vol. 7, Núm. 9

  2. Coste de eltrombopag y rituximab por paciente respondedor al tratamiento de la trombocitopenia inmune primaria en España

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 44, Núm. 6, pp. 279-287

  3. Decision-making and therapeutic options in intact splenic artery aneurysms: single-center experience and literature review

    International angiology : a journal of the International Union of Angiology, Vol. 39, Núm. 3, pp. 241-251

  4. Kinking graft—an exceptional late complication of axillofemoral bypass grafting

    Journal of Surgical Case Reports, Vol. 2020, Núm. 10

  5. Simple and complex carotid paragangliomas. Three decades of experience and literature review

    Head and Neck, Vol. 42, Núm. 12, pp. 3538-3550

  6. Spontaneous rupture of a mechanical valve in a mitral position (On-X) with migration-embolization to aortic bifurcation from the perspective of the vascular surgeon

    The Journal of cardiovascular surgery, Vol. 61, Núm. 2, pp. 256-263